NEW YORK (GenomeWeb) – MDxHealth has exclusively licensed Ghent University's proprietary molecular diagnostic visualization technology to enable the detection of cancer associated epigenetic changes in both tissue and liquid samples, the company said today.

Separately, the two parties forged a research and development agreement to develop in vitro diagnostic kits and laboratory-developed tests based on the technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.